WHO recommends COVID-19 drug and urges transparency around pricing
UN NEWS—A highly successful COVID-19 therapy must be made available to more people, the World Health Organization (WHO) has said, calling for wider distribution and greater transparency surrounding its pricing. WHO announced on Friday in Geneva that it has strongly recommended use of nirmatrelvir and ritonavir, sold